Nifty’s short-term outlook remains positive, with a potential range-bound movement in the coming sessions. However, a decisive move above 24,400 could spark a significant market rally, according to HDFC Securities’ Nagaraj Shetti.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,